Intellia Therapeutics
NTLA
NTLA
275 hedge funds and large institutions have $1.8B invested in Intellia Therapeutics in 2025 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 101 increasing their positions, 77 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 38
0.96% more ownership
Funds ownership: 96.08% → 97.04% (+0.96%)
0% less funds holding
Funds holding: 276 → 275 (-1)
Holders
275
Holding in Top 10
3
Calls
$62.6M
Puts
$32.1M
Top Buyers
| 1 | +$74.9M | |
| 2 | +$38.5M | |
| 3 | +$32.9M | |
| 4 |
D.E. Shaw & Co
New York
|
+$24.2M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$23.5M |
Top Sellers
| 1 | -$19M | |
| 2 | -$18.2M | |
| 3 | -$17.6M | |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$14.8M |
| 5 |
BlackRock
New York
|
-$13M |
